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background: The introduction of transcatheter aortic valve replacement (TAVR) has renewed interest in balloon aortic valvuloplasty (BAV) for 
severe aortic stenosis (AS). It is unclear whether technical advances and increased experience associated with TAVR development have resulted in 
improved BAV outcomes. We performed meta-analyses of all BAV studies and examined the indications, hemodynamic outcomes, and procedural 
complications of BAV in the contemporary era.
Method: A literature search from February 1987 through June 2013 was conducted for all studies reporting BAV outcomes. Studies with < 50 BAV 
procedures were excluded. BAV outcomes were compared in studies enrolling patients in the early/pre-TAVR and contemporary/post-TAVR periods 
(before vs. after 2005).
results: 27 studies representing 4,123 patients were included (Table). In the contemporary era, BAV was performed as a bridge to TAVR in 
23.4% of patients. There were significant improvements in trans-aortic valvular gradients, aortic valve area, and cardiac output following BAV in all 
time periods. There was also a significant reduction in procedural death, in-hospital mortality, and major vascular complications in contemporary 
compared to early studies, with similar rates of myocardial infarction, stroke, severe aortic insufficiency, and tamponade.
conclusion: BAV is increasingly used as a bridge to TAVR, continues to impart significant hemodynamic improvement, and has an improved safety 
profile in the contemporary era.
